View ValuationMéthanor 将来の成長Future 基準チェック /06現在、 Méthanorの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Chemicals 収益成長11.4%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報Price Target Changed • Dec 08Price target decreased by 7.9% to €5.69Down from €6.18, the current price target is provided by 1 analyst. New target price is 81% above last closing price of €3.14. Stock is down 13% over the past year. The company is forecast to post earnings per share of €0.28 for next year compared to €0.64 last year.Price Target Changed • May 09Price target increased by 7.3% to €6.16Up from €5.74, the current price target is provided by 1 analyst. New target price is 74% above last closing price of €3.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of €0.57 next year compared to a net loss per share of €0.43 last year.Price Target Changed • Jan 03Price target decreased to €5.35Down from €5.85, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €4.10. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.23 for next year compared to €0.11 last year.すべての更新を表示Recent updatesNew Risk • Jun 27New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$93k). Market cap is less than US$10m (€7.00m market cap, or US$8.19m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.Buy Or Sell Opportunity • May 27Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 24% to €2.20. The fair value is estimated to be €2.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 65% over the last 3 years. Meanwhile, the company became loss making.New Risk • Apr 30New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2023 fiscal period end). Revenue is less than US$1m. Market cap is less than US$10m (€5.29m market cap, or US$6.01m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results.Valuation Update With 7 Day Price Move • Apr 23Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €2.21, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in France. Total loss to shareholders of 45% over the past three years.Buy Or Sell Opportunity • Apr 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.8% to €2.21. The fair value is estimated to be €2.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%.Valuation Update With 7 Day Price Move • Feb 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.91, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 21x in the Chemicals industry in France. Total loss to shareholders of 27% over the past three years.Buy Or Sell Opportunity • Jan 15Now 31% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.7% to €2.02. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%.Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.35, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 44% over the past three years.New Risk • Jan 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.9% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.46m market cap, or US$4.62m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).New Risk • Nov 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.43m market cap, or US$4.61m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).New Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€4.60m market cap, or US$4.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.1% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).Buy Or Sell Opportunity • Aug 29Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €2.28. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%.Buy Or Sell Opportunity • Aug 13Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €2.34. The fair value is estimated to be €2.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%.New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€5.87m market cap, or US$6.31m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).お知らせ • May 26Méthanor SCA, Annual General Meeting, Jun 28, 2024Méthanor SCA, Annual General Meeting, Jun 28, 2024. Location: 24 rue de clichy, paris FranceNew Risk • Apr 05New major risk - Revenue and earnings growthEarnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€7.02m market cap, or US$7.61m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).Buy Or Sell Opportunity • Mar 13Now 21% overvaluedOver the last 90 days, the stock has fallen 2.2% to €3.07. The fair value is estimated to be €2.55, however this is not to be taken as a sell recommendation but rather should be used as a guide only.New Risk • Jan 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 21% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (€80k revenue, or US$87k). Market cap is less than US$10m (€7.28m market cap, or US$7.94m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).New Risk • Dec 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$86k). Market cap is less than US$10m (€6.38m market cap, or US$6.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results.Price Target Changed • Dec 08Price target decreased by 7.9% to €5.69Down from €6.18, the current price target is provided by 1 analyst. New target price is 81% above last closing price of €3.14. Stock is down 13% over the past year. The company is forecast to post earnings per share of €0.28 for next year compared to €0.64 last year.Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €3.40, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 13x in the Chemicals industry in France. Total loss to shareholders of 28% over the past three years.New Risk • Oct 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$85k). Market cap is less than US$10m (€6.11m market cap, or US$6.48m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.0% average weekly change). Large one-off items impacting financial results.Upcoming Dividend • Jun 29Upcoming dividend of €0.15 per share at 3.9% yieldEligible shareholders must have bought the stock before 06 July 2023. Payment date: 28 July 2023. Trailing yield: 3.9%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (2.0%).Price Target Changed • May 09Price target increased by 7.3% to €6.16Up from €5.74, the current price target is provided by 1 analyst. New target price is 74% above last closing price of €3.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of €0.57 next year compared to a net loss per share of €0.43 last year.お知らせ • Dec 23An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million.An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million on December 21, 2022. An unknown buyer completed the acquisition of portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) on December 21, 2022.Price Target Changed • Jan 03Price target decreased to €5.35Down from €5.85, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €4.10. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.23 for next year compared to €0.11 last year.Valuation Update With 7 Day Price Move • Dec 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €4.05, the stock trades at a trailing P/E ratio of 32.9x. Average trailing P/E is 18x in the Oil and Gas industry in France. Total loss to shareholders of 4.3% over the past three years.Upcoming Dividend • Jul 06Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 13 July 2021. Payment date: 04 August 2021. Trailing yield: 2.0%. Lower than top quartile of French dividend payers (3.7%). Lower than average of industry peers (6.7%).Is New 90 Day High Low • Oct 26New 90-day low: €4.90The company is down 16% from its price of €5.80 on 28 July 2020. The French market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 12% over the same period.Is New 90 Day High Low • Oct 08New 90-day low: €5.05The company is down 18% from its price of €6.15 on 10 July 2020. The French market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 11% over the same period.Is New 90 Day High Low • Sep 23New 90-day low: €5.20The company is down 4.0% from its price of €5.40 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Oil and Gas industry, which is down 14% over the same period. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Méthanor は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測ENXTPA:ALMET - アナリストの将来予測と過去の財務データ ( )EUR Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/202501N/AN/AN/A9/30/202501N/AN/AN/A6/30/202501N/AN/AN/A3/31/202500N/AN/AN/A12/31/20240-1N/AN/AN/A12/31/2023N/A0N/AN/AN/A12/31/202201N/AN/AN/A9/30/202200N/AN/AN/A6/30/20220-1N/AN/AN/A3/31/20220-1N/AN/AN/A12/31/20210-1N/AN/AN/A9/30/202100N/AN/AN/A6/30/2021N/A0N/AN/AN/A3/31/2021N/A0N/AN/AN/A12/31/2020N/A0N/AN/AN/A9/30/2020N/A0N/AN/AN/A6/30/2020N/A0N/AN/AN/A3/31/2020N/A0N/AN/AN/A12/31/2019N/A0N/AN/AN/A9/30/201900N/AN/AN/A6/30/201900N/AN/AN/A3/31/201900N/AN/AN/A12/31/2018N/A0N/AN/AN/A9/30/201800N/AN/AN/A6/30/201800N/AN/AN/A3/31/201800N/AN/AN/A12/31/201700N/AN/AN/A9/30/201700N/AN/AN/A6/30/201700N/AN/AN/A3/31/201700N/AN/AN/A12/31/201600N/AN/AN/A6/30/201600N/AN/AN/A3/31/201600N/AN/AN/A12/31/201500N/AN/AN/A6/30/201500N/AN/AN/Aもっと見るアナリストによる今後の成長予測収入対貯蓄率: ALMETの予測収益成長が 貯蓄率 ( 2.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: ALMETの収益がFrench市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: ALMETの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: ALMETの収益がFrench市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: ALMETの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: ALMETの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YMaterials 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/05/14 05:24終値2026/05/14 00:00収益2025/12/31年間収益2025/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Méthanor SCA 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。1 アナリスト機関Nicolas RoyotPortzamparc BNP Paribas
Price Target Changed • Dec 08Price target decreased by 7.9% to €5.69Down from €6.18, the current price target is provided by 1 analyst. New target price is 81% above last closing price of €3.14. Stock is down 13% over the past year. The company is forecast to post earnings per share of €0.28 for next year compared to €0.64 last year.
Price Target Changed • May 09Price target increased by 7.3% to €6.16Up from €5.74, the current price target is provided by 1 analyst. New target price is 74% above last closing price of €3.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of €0.57 next year compared to a net loss per share of €0.43 last year.
Price Target Changed • Jan 03Price target decreased to €5.35Down from €5.85, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €4.10. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.23 for next year compared to €0.11 last year.
New Risk • Jun 27New major risk - Revenue and earnings growthEarnings have declined by 24% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (13% average weekly change). Earnings have declined by 24% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$93k). Market cap is less than US$10m (€7.00m market cap, or US$8.19m). Minor Risk Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past.
Buy Or Sell Opportunity • May 27Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 24% to €2.20. The fair value is estimated to be €2.78, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 65% over the last 3 years. Meanwhile, the company became loss making.
New Risk • Apr 30New major risk - Financial data availabilityThe company's latest financial reports are more than a year old. Last reported fiscal period ended December 2023. This is considered a major risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. In the worst case scenario, it may be facing other major going concern issues jeopardizing its viability as a listed company. Currently, the following risks have been identified for the company: Major Risks Latest financial reports are more than 1 year old (reported December 2023 fiscal period end). Revenue is less than US$1m. Market cap is less than US$10m (€5.29m market cap, or US$6.01m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (11% average weekly change). Large one-off items impacting financial results.
Valuation Update With 7 Day Price Move • Apr 23Investor sentiment deteriorates as stock falls 18%After last week's 18% share price decline to €2.21, the stock trades at a trailing P/E ratio of 17.9x. Average trailing P/E is 18x in the Chemicals industry in France. Total loss to shareholders of 45% over the past three years.
Buy Or Sell Opportunity • Apr 23Now 21% undervalued after recent price dropOver the last 90 days, the stock has fallen 9.8% to €2.21. The fair value is estimated to be €2.79, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%.
Valuation Update With 7 Day Price Move • Feb 05Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €2.91, the stock trades at a trailing P/E ratio of 23.6x. Average trailing P/E is 21x in the Chemicals industry in France. Total loss to shareholders of 27% over the past three years.
Buy Or Sell Opportunity • Jan 15Now 31% undervalued after recent price dropOver the last 90 days, the stock has fallen 4.7% to €2.02. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 100% over the last year. Earnings per share has declined by 81%.
Valuation Update With 7 Day Price Move • Jan 14Investor sentiment improves as stock rises 26%After last week's 26% share price gain to €2.35, the stock trades at a trailing P/E ratio of 19.1x. Average trailing P/E is 20x in the Chemicals industry in France. Total loss to shareholders of 44% over the past three years.
New Risk • Jan 01New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.9% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.9% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.46m market cap, or US$4.62m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).
New Risk • Nov 22New major risk - Share price stabilityThe company's share price has been highly volatile over the past 3 months. It is more volatile than 90% of French stocks, typically moving 9.1% a week. This is considered a major risk. Share price volatility increases the risk of potential losses in the short-term as the stock tends to have larger drops in price more frequently than other stocks. It may also indicate the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. Currently, the following risks have been identified for the company: Major Risks Share price has been highly volatile over the past 3 months (9.1% average weekly change). Revenue is less than US$1m. Market cap is less than US$10m (€4.43m market cap, or US$4.61m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).
New Risk • Nov 15New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2023. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m. Market cap is less than US$10m (€4.60m market cap, or US$4.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2023 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (9.1% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (19% increase in shares outstanding).
Buy Or Sell Opportunity • Aug 29Now 22% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €2.28. The fair value is estimated to be €2.93, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%.
Buy Or Sell Opportunity • Aug 13Now 20% undervalued after recent price dropOver the last 90 days, the stock has fallen 12% to €2.34. The fair value is estimated to be €2.94, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 93% over the last 3 years. Earnings per share has grown by 30%.
New Risk • Jun 10New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.7% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€5.87m market cap, or US$6.31m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.7% average weekly change). Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).
お知らせ • May 26Méthanor SCA, Annual General Meeting, Jun 28, 2024Méthanor SCA, Annual General Meeting, Jun 28, 2024. Location: 24 rue de clichy, paris France
New Risk • Apr 05New major risk - Revenue and earnings growthEarnings have declined by 19% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 19% per year over the past 5 years. Revenue is less than US$1m. Market cap is less than US$10m (€7.02m market cap, or US$7.61m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).
Buy Or Sell Opportunity • Mar 13Now 21% overvaluedOver the last 90 days, the stock has fallen 2.2% to €3.07. The fair value is estimated to be €2.55, however this is not to be taken as a sell recommendation but rather should be used as a guide only.
New Risk • Jan 25New minor risk - Shareholder dilutionThe company's shareholders have been diluted in the past year. Increase in shares outstanding: 21% This is considered a minor risk. Shareholder dilution occurs when there is an increase in the number of shares on issue that is not proportionally distributed between all shareholders. Often due to the company raising equity capital or some options being converted into stock. All else being equal, if there are more shares outstanding then each existing share will be entitled to a lower proportion of the company's total earnings, thus reducing earnings per share (EPS). While dilution might not always result in lower EPS (like if the company is using the capital to fund an EPS accretive acquisition) in a lot cases it does, along with lower dividends per share and less voting power at shareholder meetings. Currently, the following risks have been identified for the company: Major Risks Revenue is less than US$1m (€80k revenue, or US$87k). Market cap is less than US$10m (€7.28m market cap, or US$7.94m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Large one-off items impacting financial results. Shareholders have been diluted in the past year (21% increase in shares outstanding).
New Risk • Dec 11New minor risk - Financial data availabilityThe company's latest financial reports are more than 6 months old. Last reported fiscal period ended December 2022. This is considered a minor risk. If the company has not reported its earnings on time, it may have been delayed due to audit problems or it may be finding it difficult to reconcile its accounts. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$86k). Market cap is less than US$10m (€6.38m market cap, or US$6.86m). Minor Risks Latest financial reports are more than 6 months old (reported December 2022 fiscal period end). Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.8% average weekly change). Large one-off items impacting financial results.
Price Target Changed • Dec 08Price target decreased by 7.9% to €5.69Down from €6.18, the current price target is provided by 1 analyst. New target price is 81% above last closing price of €3.14. Stock is down 13% over the past year. The company is forecast to post earnings per share of €0.28 for next year compared to €0.64 last year.
Valuation Update With 7 Day Price Move • Nov 01Investor sentiment improves as stock rises 16%After last week's 16% share price gain to €3.40, the stock trades at a trailing P/E ratio of 5.4x. Average trailing P/E is 13x in the Chemicals industry in France. Total loss to shareholders of 28% over the past three years.
New Risk • Oct 20New minor risk - Share price stabilityThe company's share price has been volatile over the past 3 months. It is more volatile than 75% of French stocks, typically moving 6.0% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Earnings have declined by 20% per year over the past 5 years. Revenue is less than US$1m (€80k revenue, or US$85k). Market cap is less than US$10m (€6.11m market cap, or US$6.48m). Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Share price has been volatile over the past 3 months (6.0% average weekly change). Large one-off items impacting financial results.
Upcoming Dividend • Jun 29Upcoming dividend of €0.15 per share at 3.9% yieldEligible shareholders must have bought the stock before 06 July 2023. Payment date: 28 July 2023. Trailing yield: 3.9%. Lower than top quartile of French dividend payers (5.2%). Higher than average of industry peers (2.0%).
Price Target Changed • May 09Price target increased by 7.3% to €6.16Up from €5.74, the current price target is provided by 1 analyst. New target price is 74% above last closing price of €3.54. Stock is down 16% over the past year. The company is forecast to post earnings per share of €0.57 next year compared to a net loss per share of €0.43 last year.
お知らせ • Dec 23An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million.An unknown buyer acquired portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) for €1.9 million on December 21, 2022. An unknown buyer completed the acquisition of portfolio of two hydroelectric power stations from Méthanor SCA (ENXTPA:ALMET) on December 21, 2022.
Price Target Changed • Jan 03Price target decreased to €5.35Down from €5.85, the current price target is provided by 1 analyst. New target price is 30% above last closing price of €4.10. Stock is down 19% over the past year. The company is forecast to post earnings per share of €0.23 for next year compared to €0.11 last year.
Valuation Update With 7 Day Price Move • Dec 27Investor sentiment deteriorated over the past weekAfter last week's 15% share price decline to €4.05, the stock trades at a trailing P/E ratio of 32.9x. Average trailing P/E is 18x in the Oil and Gas industry in France. Total loss to shareholders of 4.3% over the past three years.
Upcoming Dividend • Jul 06Upcoming dividend of €0.10 per shareEligible shareholders must have bought the stock before 13 July 2021. Payment date: 04 August 2021. Trailing yield: 2.0%. Lower than top quartile of French dividend payers (3.7%). Lower than average of industry peers (6.7%).
Is New 90 Day High Low • Oct 26New 90-day low: €4.90The company is down 16% from its price of €5.80 on 28 July 2020. The French market is up 1.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 12% over the same period.
Is New 90 Day High Low • Oct 08New 90-day low: €5.05The company is down 18% from its price of €6.15 on 10 July 2020. The French market is flat over the last 90 days, indicating the company underperformed over that time. It also underperformed the Oil and Gas industry, which is down 11% over the same period.
Is New 90 Day High Low • Sep 23New 90-day low: €5.20The company is down 4.0% from its price of €5.40 on 25 June 2020. The French market is down 1.0% over the last 90 days, indicating the company underperformed over that time. However, it outperformed the Oil and Gas industry, which is down 14% over the same period.